Google Life Sciences edges into Theranos terrain with needle-free, micro blood

Google has filed a patent for a “needle-free blood draw” system that can be used either as a wearable on a person’s wrist or as a hand-held device that takes blood from a fingertip or other parts of the body, reports The Verge.

According to the patent, which is awaiting approval and publication, the functionality of the system involves a micro-particle that breaks the skin. When blood protrudes from the puncture wound, the negative pressure in the barrel will suck the blood into the container for analysis.

This is not the first time Google has ventured into the world of blood-glucose testing. Such an application might be used to draw a small amount of blood, for example, for a glucose test for the patents diagnosed with diabetes, Google explains.

The needle free system could have many applications.

Google has already filed a patent for a “needle-free blood draw” device.

It is worth noting that Google holds patents on a variety of a different ideas and not all will make it into production.

These devices, smart contact lenses and cloud-connected sensor (which is the size of a bandage), will aid the diabetics track their blood sugar levels. If Google succeeds in its projects about diabetes and gets clearance from FDA, it could boost the business for Google as about 29 million people in the USA have diabetes. With the gradual increase in the field of science, new technologies are being developed; one amongst them is getting blood without inserting needle. As of the moment, the wrist device appearing in the patent has a poor and large design that can be termed “substandard”. Patents are complex and are not an assurance of a real product.